{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:21:55Z","timestamp":1793647315035,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001454","name":"American Epilepsy Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001454","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001605","name":"Epilepsy Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007249","name":"University of Minnesota","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007249","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001797","name":"Pharmaceutical Research and Manufacturers of America Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01HL127479"],"award-info":[{"award-number":["U01HL127479"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jconrel.2025.114250","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:10:54Z","timestamp":1758575454000},"page":"114250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Progress towards a prodrug\/enzyme intranasal delivery system for rapid prevention\/reversal of seizure emergency"],"prefix":"10.1016","volume":"387","author":[{"given":"Ronald A.","family":"Siegel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davin","family":"Rautiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsihmulu","family":"Cheryala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunda I.","family":"Georg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Cloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114250_bb0005","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","article-title":"Treatment of convulsive status epilepticus. Recommendations of the epilepsy foundation of America\u2019s Working Group on status epilepticus","volume":"270","author":"Working Group on Status Epilepticus","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.jconrel.2025.114250_bb0010","first-page":"497","article-title":"Initial management of acute seizures and status epilepticus","volume":"109","author":"Haider","year":"2025","journal-title":"Med. Clin."},{"key":"10.1016\/j.jconrel.2025.114250_bb0015","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s40263-022-00940-2","article-title":"Benzodiazepines in the management of seizures and status epilepticus: a review of routes of delivery, pharmacokinetics, efficacy, and tolerability","volume":"36","author":"Kienitz","year":"2022","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2025.114250_bb0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/epi.14479","article-title":"Rescue therapies for seizure emergencies: new modes of administration","volume":"59","author":"Maglalang","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.jconrel.2025.114250_bb0025","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0887-8994(98)00156-8","article-title":"Rectal diazepam gel for treatment of acute repetitive seizures, the north American Diastat study group","volume":"20","author":"Kriel","year":"1999","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jconrel.2025.114250_bb0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2016.07.001","article-title":"A review of intranasal formulations for the treatment of seizure emergencies","volume":"237","author":"Kapoor","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114250_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40263-023-01060-1","article-title":"Benzodiazepines for the treatment of seizure clusters","volume":"38","author":"Penovich","year":"2024","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jconrel.2025.114250_bb0040","first-page":"62","article-title":"Intranasal administration of antiseizure medications in chronic and emergency treatment: hopes and challenges","volume":"115","author":"Chmielewska","year":"2024","journal-title":"Eur. J. Epilepsy"},{"key":"10.1016\/j.jconrel.2025.114250_bb0045","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of midazolam nasal spray","volume":"171","author":"Ren\u00e9 Bouw","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jconrel.2025.114250_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/neurolint13010007","article-title":"VALTOCO\u00ae (diazepam nasal spray) for the acute treatment of intermittent stereotypic episodes of frequent seizure activity","volume":"13","author":"Cornett","year":"2021","journal-title":"Neurol. Int."},{"key":"10.1016\/j.jconrel.2025.114250_bb0055","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1208\/s12248-014-9596-5","article-title":"Rapid delivery of diazepam from supersaturated solutions prepared using prodrug-enzyme mixtures: toward intranasal treatment of seizure emergencies","volume":"16","author":"Kapoor","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2025.114250_bb0060","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1016\/j.yebeh.2015.05.004","article-title":"Water soluble benzodiazepine prodrug\/enzyme combinations for intranasal rescue therapies","volume":"49","author":"Siegel","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.jconrel.2025.114250_bb0065","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.xphs.2016.05.011","article-title":"Chirally pure prodrugs and their converting enzymes lead to high supersaturation and rapid transcellular permeation of benzodiazepines","volume":"105","author":"Kapoor","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114250_bb0070","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1124\/jpet.118.255943","article-title":"Intranasal coadministration of a diazepam prodrug with a converting enzyme results in rapid absorption of diazepam in rats","volume":"370","author":"Rautiola","year":"2018","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.jconrel.2025.114250_bb0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0376-7388(00)82254-1","article-title":"Transference: a comprehensive parameter governing permeation of solutes through membranes","volume":"1","author":"Theeuwes","year":"1976","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2025.114250_bb0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jps.20600","article-title":"Enhanced permeation of diazepam through artificial membranes from supersaturated solutions","volume":"95","author":"Hou","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2025.114250_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2018.09.013","article-title":"Conversion of a soluble diazepam prodrug to supersaturated diazepam for rapid intranasal delivery: kinetics and stability","volume":"389","author":"Rautiola","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114250_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2014.06.053","article-title":"Quantitative analysis of drug delivery to the brain via nasal route","volume":"189","author":"Kozlovskaya","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114250_bb0095","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijpharm.2008.07.030","article-title":"Pharmacokinetics and brain uptake of diazepam after intravenous and intranasal administration in rats and rabbits","volume":"364","author":"Kaur","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2025.114250_bb0100","doi-asserted-by":"crossref","unstructured":"D. Rautiola, J.L. Updyke, K.M Nelson, R.A. Siegel, Diazepam prodrug stabilizes human aminopeptidase B during lyophilization, Mol. Pharm. 17 (2020) 453\u2013460.","DOI":"10.1021\/acs.molpharmaceut.9b00880"},{"key":"10.1016\/j.jconrel.2025.114250_bb0105","series-title":"Two-Part Reactive Formulations for Intranasal Delivery of Benzodiazepines","author":"Rautiola","year":"2019"},{"key":"10.1016\/j.jconrel.2025.114250_bb0110","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1111\/epi.16521","article-title":"Seizure detection at home: do devices on the market match the needs of people living with epilepsy and their caregivers?","volume":"61","author":"Bruno","year":"2020","journal-title":"Epilepsia"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365925008624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T08:56:11Z","timestamp":1780476971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365925008624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":22,"alternative-id":["S0168365925008624"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114250","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress towards a prodrug\/enzyme intranasal delivery system for rapid prevention\/reversal of seizure emergency","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114250"}}